Greenfield, brownfield or O&M: what each does to the brand
Building, buying or managing a hospital each leaves the group with a different brand exposure, a different inherited footprint and a different demand engine to build.
Healthcare growth strategy in India is usually written about by consultants. This section is the operator’s account of owning the topline in a hospital group: the revenue engine and the three demand pools it runs on, reading the monthly P&L pack, pricing, sales, and launching new verticals and care formats with a P&L attached. It covers Centres of Excellence from the digital and brand side — oncology, transplant, genomics, mental health, cardiac — the international patient funnel as a digital product, capital cases built from demand evidence, brand architecture across a multi-unit group, and innovation that survives contact with finance. The position throughout is the same: the person who built the demand and digital engine, and grew into owning the P&L conversations behind it.
Building, buying or managing a hospital each leaves the group with a different brand exposure, a different inherited footprint and a different demand engine to build.
Genomics is a demand-creation problem dressed as a lab line, and treating it as capture leaves the sequencer idle and the capital case under review.
What a consultant’s search footprint, reviews and referral base are worth to a unit’s P&L, how to assess them before the guarantee is signed, and the onboarding that earns it.
Cardiac volume is sent, not searched, so the doctor-facing product, report turnaround, the emergency line and the referrer CRM matter more than the patient page.
One name, many names or a house of brands: what each costs a hospital group in entity structure, search cannibalisation, review aggregation, doctor affiliation and migration.
Lead ownership, multilingual response, document workflows, quote governance and commission on a system the group owns, built to serve the relationships rather than police them.
A Centre of Excellence is a promise the group makes in public, and it is heard, tested and judged on digital surfaces the clinical team never sees.
What changes when a growth leader is asked for a number instead of a campaign: capital discipline, cross-functional trade-offs and a new relationship with unit heads.
Catchment, referred and institutional demand need different owners, metrics and investment logic, and forcing them through one funnel hides which one is failing.
Where growth and clinical governance collide in a hospital group, what a working partnership with the medical director looks like, and the lines growth must never cross.